What are the indications and main therapeutic effects of Vigabatrin (vigabatrin)?

Vigabatrin (Vigabatrin) is an anti-epileptic drug that mainly inhibits the decomposition of γ-aminobutyric acid (GABA) in the nervous system, thereby enhancing the inhibitory effect of GABA and reducing the abnormal excitability of neurons. As a drug with a unique mechanism, Vigabatrin is widely used to treat certain types of epilepsy, especially for patients who do not respond well to conventional anti-epileptic drugs, providing a new treatment option.

In terms of indications, Vigabatrin is mainly used to treat refractory complex partial epilepsy, and is usually used as an auxiliary drug in combination with other anti-epileptic drugs. In addition, Vigabatrin is also one of the important therapeutic drugs for infantile spasms (West syndrome), especially showing good efficacy in infantile spasms caused by tuberous sclerosis. Vigabatrin can help reduce the frequency and severity of epileptic seizures by effectively increasing GABA concentrations in the brain.

Although Vigabatrin has outstanding efficacy, its use is also accompanied by certain risks, especially the problem of visual field defects. Long-term use of Vigabatrin may cause irreversible narrowing of the visual field, so patients need to have a baseline visual examination before starting treatment and regular re-examination during treatment. Doctors usually develop an individualized treatment plan based on weighing the efficacy and risks to ensure that the drug's effect is maximized while reducing potential adverse reactions.

Overall, Vigabatrin plays an important role in the treatment of refractory epilepsy and infantile spasms, bringing new hope to many patients to control their conditions. However, patients need to closely cooperate with the doctor's monitoring and guidance during use, conduct relevant examinations regularly, and use medications rationally in order to obtain good therapeutic effects while ensuring safety.

Reference materials:https://www.sabril.net/